[HTML][HTML] Curcumin's nanomedicine formulations for therapeutic application in neurological diseases

B Salehi, D Calina, AO Docea, N Koirala… - Journal of Clinical …, 2020 - mdpi.com
The brain is the body's control center, so when a disease affects it, the outcomes are
devastating. Alzheimer's and Parkinson's disease, and multiple sclerosis are brain diseases …

Alzheimer′ s disease and the amyloid cascade hypothesis: a critical review

C Reitz - International journal of Alzheimer's disease, 2012 - Wiley Online Library
Since 1992, the amyloid cascade hypothesis has played the prominent role in explaining the
etiology and pathogenesis of Alzheimer′ s disease (AD). It proposes that the deposition of …

Curcumin labels amyloid pathology in vivo, disrupts existing plaques, and partially restores distorted neurites in an Alzheimer mouse model

M Garcia‐Alloza, LA Borrelli, A Rozkalne… - Journal of …, 2007 - Wiley Online Library
Alzheimer's disease (AD) is characterized by senile plaques and neurodegeneration
although the neurotoxic mechanisms have not been completely elucidated. It is clear that …

What causes Alzheimer's disease?

RA Armstrong - Folia neuropathologica, 2013 - termedia.pl
Since the earliest descriptions of Alzheimer's disease (AD), many theories have been
advanced as to its cause. These include:(1) exacerbation of aging,(2) degeneration of …

An overview of the intrinsic role of citrullination in autoimmune disorders

M Alghamdi, D Alasmari, A Assiri… - Journal of …, 2019 - Wiley Online Library
A protein undergoes many types of posttranslation modification. Citrullination is one of these
modifications, where an arginine amino acid is converted to a citrulline amino acid. This …

[HTML][HTML] Microbial-generated amyloids and Alzheimer's disease (AD)

JM Hill, WJ Lukiw - Frontiers in aging neuroscience, 2015 - frontiersin.org
Atypical amyloid generation, folding, aggregation and impaired clearance are characteristic
pathological features of human neurodegenerative disorders including Alzheimer's disease …

[HTML][HTML] post-ischemic permeability of the blood–brain barrier to amyloid and platelets as a factor in the maturation of Alzheimer's Disease-type brain …

R Pluta, B Miziak, SJ Czuczwar - International Journal of Molecular …, 2023 - mdpi.com
The aim of this review is to present evidence of the impact of ischemic changes in the blood–
brain barrier on the maturation of post-ischemic brain neurodegeneration with features of …

[HTML][HTML] Microbial sources of amyloid and relevance to amyloidogenesis and Alzheimer's disease (AD)

Y Zhao, P Dua, WJ Lukiw - Journal of Alzheimer's disease & …, 2015 - ncbi.nlm.nih.gov
Since the inception of the human microbiome project (HMP) by the US National Institutes of
Health (NIH) in 2007 there has been a keen resurgence in our recognition of the human …

The molecular biology of senile plaques and neurofibrillary tangles in Alzheimer's disease

RA Armstrong - Folia Neuropathologica, 2009 - termedia.pl
Since the earliest descriptions of the disease, senile plaques (SP) and neurofibrillary tangles
(NFT) have been regarded as the pathological 'hallmarks' of Alzheimer's disease (AD) …

Amyloid-β peptide (Aβ) neurotoxicity is modulated by the rate of peptide aggregation: Aβ dimers and trimers correlate with neurotoxicity

LW Hung, GD Ciccotosto, E Giannakis… - Journal of …, 2008 - Soc Neuroscience
Alzheimer's disease is an age-related neurodegenerative disorder with its toxicity linked to
the generation of amyloid-β peptide (Aβ). Within the Aβ sequence, there is a systemic repeat …